Skip to main content
SpringerLink
Log in

Further characterization of the putative 5-HT4 receptor mediating depolarization of the rat isolated vagus nerve

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

A putative 5-HT4 receptor-mediated depolarization of the rat isolated vagus nerve has been studied using a grease-gap extracellular recording technique. Ondansetron (1 μM) was used to block the predominant 5-HT3 receptor mediated depolarization in this preparation and the effects of the 5-HT4 receptor antagonists DAU 6285 (endo-8-methyl-8-azabicyclo [3.2.1] oct-3-y1-2,3-dihydro-6-methoxy-2-oxo-1H-benzimidazole-1-carboxylate HCl); 0.3, 1.0 or 3.0 μM and SDZ 205–557 (2-methoxy-4-amino-5-chloro-benzoic acid 2-(diethylamino)-ethyl ester HCl); 0.1, 0.3 or 1.0 μM were studied on the residual, ondansetron-resistant, component of the response. The effects of the phosphodiesterase inhibitor isobutylmethylxanthine (IBMX) and of forskolin on the ondansetron-resistant response were also studied.

Both DAU 6285 and SDZ 205–557 acted as competitive antagonists of the ondansetron-resistant response to 5-HT with pA2 values of 6.8 (6.7–7.1, n = 12) and 7.1 (6.9–7.5, n = 12) respectively. The vagus nerve was depolarized by IBMX (100 μM) or forskolin (10 μM), the effects being similar to the maximum response to 5-HT. In the presence of IBMX (100 μM) or forskolin (10 μM) the ondansetron-resistant component of the response to 5-HT was enhanced and the 5-HT3 receptor-mediated component reduced.

These results with DAU 6285 and SDZ 205-557 are consistent with a 5-HT4 receptor-mediated mechanism of the ondansetron-resistant depolarizing response to 5-HT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14:48–58

    Google Scholar 

  • Barker D, Coleman J, Lattimer N, Rhodes KF (1994) An ondansetron-resistant component of 5-HT-evoked depolarization is present in the vagus nerves of the rat and mouse but not of the guinea-pig or rabbit. Br J Pharmacol 112:175P.

    Google Scholar 

  • Bley KR, Eglen RM (1993) Characterization of a 5-hydroxytryptaminergic depolarization in the rat isolated vagus nerve. Br J Pharmacol 108:246P

    Google Scholar 

  • Bley KR, Eglen RM, Wong EHF (1994) Characterization of 5-hydroxytryptamine-induced depolarizations in rat isolated vagus nerve. Eur J Pharmacol 260:139–147

    Google Scholar 

  • Buchheit KH, Gamse R, Pfannküche HJ (1992) SDZ 205–557, a selective, surmountable antagonist for 5-HT4 receptors in the guinea-pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 345:387–393

    Google Scholar 

  • Butler A, Hill JM, Ireland SJ, Jordan CC, Tyers MB (1988) Pharmacological properties of GR 38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol 94:397–412

    Google Scholar 

  • Coleman J, Rhodes KF (1993) The effect of the 5-H4 receptor antagonist DAU 6285 on a component of 5-HT evoked depolarization of the rat isolated vagus nerve. Br J Pharmacol 108:247P

  • Coleman J, Rhodes KF (1994) The effects of forskolin and IBMX on a putative 5-HT4 receptor-mediated depolarization of the rat vagus nerve. Br J Pharmacol 111:159P

    Google Scholar 

  • DeLean A, Munson, Rodbard D (1978) Simultaneous analysis of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. Am J Physiol 235:E97-E102

    Google Scholar 

  • Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J (1988) A non classical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34:880–887

    Google Scholar 

  • Dumuis A, Gozlan H, Sebben M, Ansanay H, Rizzi CA, Turconi M, Monferini E, Giraldo E, Schiantarelli P, Ladinsky H, Bockaert J (1992) Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazole class: DAU 6285. Naunyn-Schmiedeberg's Arch Pharmacol 345:264–269

    Google Scholar 

  • Ireland SJ, Tyers MB (1987) Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve. Br J Pharmacol 90:229–238

    Google Scholar 

  • Rhodes KF, Lattimer N, Coleman J (1992) A component of 5-HT-evoked depolarization of the rat isolated vagus nerve is mediated by a putative 5-HT4 receptor. Naunyn-Schmiedeberg's Arch Pharmacol 346:496–503

    Google Scholar 

  • Rhodes KF, Middlefell VC, Lattimer N, Brammer NT; Coleman J, Taylor AP, Saville VL, Ward TJ (1993) WAY 100289: Pharmacological profile of a novel 5-HT3 receptor antagonist. Drug Dev Res 28:128–140

    Google Scholar 

  • Schiavone A, Giraldo E, Giudici L, Turconi M, Sagrada A (1992) DAU 6285: a novel antagonist at the putative 5-HT4 receptor. Life Sci 51:583–592

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Research, Wyeth Research (UK) Ltd., Huntercombe Lane South, SL6 OPH, Maidenhead, Berkshire, UK

    J. Coleman & K. F. Rhodes

Authors
  1. J. Coleman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. F. Rhodes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coleman, J., Rhodes, K.F. Further characterization of the putative 5-HT4 receptor mediating depolarization of the rat isolated vagus nerve. Naunyn-Schmiedeberg's Arch Pharmacol 352, 74–78 (1995). https://doi.org/10.1007/BF00169192

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00169192

Key words

Search

Navigation